photo walkheader_zpsd5bunpmi.png

Monthly Archives: October 2013

ARBs for the Treatment of Pancreatic Cancer?

For more than a decade there have been theoretical discussions about the use of drugs commonly used to treat high blood pressure for use in the treatment of cancer – pancreatic cancer (ductal adenocarcinoma of the pancreas). And there have been some prior preliminary research studies. Now comes a very intriguing and elaborate pre-clinical study […]

Nanoliposomal Topoisomerase I Inhibitor for Advanced Pancreatic Cancer

There is no universally agreed upon second line treatment for metastatic pancreatic cancer (ductal adenocarcinoma of the pancreas). On August 20 2013 in the British Journal of Cancer, the results of an interesting international Phase II clinic trial using nanoliposomal irinotecan for the treatment of earlier pre-treated metastatic pancreatic cancer were published. The researchers included […]

Facebook
Facebook